Asimov is a pioneering synthetic biology startup dedicated to advancing humanity's ability to design living systems and develop biotechnologies that provide significant societal benefits. With a focus on creating a mammalian synthetic biology platform that spans from cells to software, Asimov aims to facilitate the design and manufacture of next-generation therapeutics. The company fosters a culture of diversity and collaboration, believing that a mixture of backgrounds and perspectives is essential to achieving its mission of transforming biological engineering into a fully-fledged engineering discipline.